| Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ... Diabetes care 41 (12), 2669, 2018 | 4443 | 2018 |
| Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ... Diabetes care 42 (8), 1593-1603, 2019 | 3493 | 2019 |
| Vitamin D and human health: lessons from vitamin D receptor null mice R Bouillon, G Carmeliet, L Verlinden, E van Etten, A Verstuyf, HF Luderer, ... Endocrine reviews 29 (6), 726-776, 2008 | 2434 | 2008 |
| An overview of real-time quantitative PCR: applications to quantify cytokine gene expression A Giulietti, L Overbergh, D Valckx, B Decallonne, R Bouillon, C Mathieu Methods 25 (4), 386-401, 2001 | 1965 | 2001 |
| 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study … JB Buse, DJ Wexler, A Tsapas, P Rossing, G Mingrone, C Mathieu, ... Diabetes care 43 (2), 487-493, 2020 | 1952 | 2020 |
| Vitamin D: modulator of the immune system F Baeke, T Takiishi, H Korf, C Gysemans, C Mathieu Current opinion in pharmacology 10 (4), 482-496, 2010 | 1838 | 2010 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1526 | 2018 |
| Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes B Keymeulen, E Vandemeulebroucke, AG Ziegler, C Mathieu, L Kaufman, ... New England journal of medicine 352 (25), 2598-2608, 2005 | 1331 | 2005 |
| Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts E van Etten, C Mathieu The Journal of steroid biochemistry and molecular biology 97 (1-2), 93-101, 2005 | 1234 | 2005 |
| Differentiation of diabetes by pathophysiology, natural history, and prognosis JS Skyler, GL Bakris, E Bonifacio, T Darsow, RH Eckel, L Groop, ... Diabetes 66 (2), 241-255, 2017 | 1181 | 2017 |
| Vitamin D and diabetes C Mathieu, C Gysemans, A Giulietti, R Bouillon Diabetologia 48, 1247-1257, 2005 | 1039 | 2005 |
| A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death AD Garg, DV Krysko, T Verfaillie, A Kaczmarek, GB Ferreira, T Marysael, ... The EMBO journal 31 (5), 1062-1079, 2012 | 858 | 2012 |
| The coming of age of 1, 25-dihydroxyvitamin D3 analogs as immunomodulatory agents C Mathieu, L Adorini Trends in molecular medicine 8 (4), 174-179, 2002 | 773 | 2002 |
| Initiation and execution of lipotoxic ER stress in pancreatic β-cells DA Cunha, P Hekerman, L Ladrière, A Bazarra-Castro, F Ortis, ... Journal of cell science 121 (14), 2308-2318, 2008 | 751 | 2008 |
| Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR L Overbergh, D Valckx, M Waer, C Mathieu Cytokine 11 (4), 305-312, 1999 | 695 | 1999 |
| Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene W Janssens, R Bouillon, B Claes, C Carremans, A Lehouck, I Buysschaert, ... Thorax 65 (3), 215-220, 2010 | 648 | 2010 |
| Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3 C Mathieu, M Waer, J Laureys, O Rutgeerts, R Bouillon Diabetologia 37, 552-558, 1994 | 629 | 1994 |
| Vitamin D and diabetes T Takiishi, C Gysemans, R Bouillon, C Mathieu Endocrinology and Metabolism Clinics 39 (2), 419-446, 2010 | 610 | 2010 |
| Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma PW Hellings, A Kasran, Z Liu, P Vandekerckhove, A Wuyts, L Overbergh, ... American journal of respiratory cell and molecular biology 28 (1), 42-50, 2003 | 573 | 2003 |
| Monocytes from type 2 diabetic patients have a pro-inflammatory profile: 1, 25-Dihydroxyvitamin D3 works as anti-inflammatory A Giulietti, E van Etten, L Overbergh, K Stoffels, R Bouillon, C Mathieu Diabetes research and clinical practice 77 (1), 47-57, 2007 | 539 | 2007 |